Related Experiment Video
Updated: Aug 18, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies
1Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Università degli Studi di Parma, Italy.
Abstract:
Human natural (KTAb), murine monoclonal (KTMAb), and single-chain recombinant (KTScFv) candidacidal antibodies representing the internal image of a killer toxin from the yeast Pichia anomala (KT), characterized by a wide spectrum of antibiotic activity, exerted a lethal effect against a KT-sensitive multidrug-resistant isolate of Mycobacterium tuberculosis. KTMAb and KTScFv were produced by the hybridoma and DNA technologies, respectively, from the spleen lymphocytes of animals immunized with the idiotype of a KT-neutralizing MAb (MAb KT4), while KTAb were purified against MAb KT4 from the vaginal fluid of women infected with Candida albicans cells bearing an idiotype-like KT cell wall receptor. Mycobactericidal activity was related to the binding of KTAb, KTMAb, and KTScFv to the cell surface of KT-sensitive bacterial cells and was prevented by specific absorption of KT-like antibodies onto MAb KT4. These data identify a novel potentially useful immunotherapeutic approach to tuberculosis.
Insights
Novel candidacidal antibodies demonstrated lethal effects against multidrug-resistant Mycobacterium tuberculosis. This discovery offers a promising new immunotherapeutic strategy for tuberculosis treatment.
Area of Science:
- Immunology
- Microbiology
- Biotechnology
Background:
- Antibiotic resistance in Mycobacterium tuberculosis poses a significant global health threat.
- The yeast Pichia anomala killer toxin (KT) exhibits broad-spectrum antibiotic activity.
- Internal image antibodies targeting KT were previously characterized.
Purpose of the Study:
- To investigate the efficacy of candidacidal antibodies against a multidrug-resistant Mycobacterium tuberculosis isolate.
- To explore the potential of these antibodies as an immunotherapeutic approach for tuberculosis.
Main Methods:
- Production of human natural (KTAb), murine monoclonal (KTMAb), and single-chain recombinant (KTScFv) candidacidal antibodies.
- Testing the antibodies' lethal effect on a KT-sensitive multidrug-resistant Mycobacterium tuberculosis isolate.
- Assessing antibody binding to bacterial cell surfaces and inhibition by specific absorption.
Main Results:
- KTAb, KTMAb, and KTScFv exhibited a lethal effect against the multidrug-resistant Mycobacterium tuberculosis isolate.
- Mycobactericidal activity correlated with antibody binding to the bacterial cell surface.
- Binding was specifically inhibited by absorption with MAb KT4.
Conclusions:
- Candidacidal antibodies targeting the Pichia anomala killer toxin internal image show potent activity against multidrug-resistant Mycobacterium tuberculosis.
- These findings suggest a novel and potentially effective immunotherapeutic strategy for tuberculosis.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Bacterial Toxins

